COCA COLA CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that COCA COLA CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.94B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $47.06B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $45.75B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $43.00B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $38.66B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $33.01B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $37.27B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $34.30B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $36.21B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $41.86B | Feb 21, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.54B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $28.74B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $27.23B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $25.00B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $23.30B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $19.58B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $22.65B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $21.23B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $22.49B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $25.40B | Feb 21, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.11B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $10.63B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $10.71B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $9.54B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $9.77B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $7.75B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $8.92B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $6.43B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.25B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $6.53B | Feb 21, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.76B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $9.99B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $11.31B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $10.91B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $10.31B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $9.00B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $10.09B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $9.15B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $7.76B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $8.66B | Feb 21, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.52B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $14.58B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $13.97B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $12.88B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $12.14B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $9.73B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $12.10B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $11.00B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $12.83B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $15.37B | Feb 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.41B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $6.81B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $11.60B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $11.02B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $12.63B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $9.84B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $10.47B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $7.63B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $7.04B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $8.79B | Feb 21, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.11B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $2.06B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.85B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $1.48B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.37B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $1.18B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $2.05B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $1.55B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.75B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $2.26B | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $104.82B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $100.55B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $97.70B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $92.76B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $94.35B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $87.30B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $86.38B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $83.22B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $87.90B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $87.27B | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.17B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $24.86B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $25.94B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $24.11B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $23.00B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $19.30B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $18.98B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $16.98B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $17.07B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $23.06B | Feb 23, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.49B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $18.14B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $18.36B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $18.78B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $19.36B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $17.51B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $16.76B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $14.11B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $13.65B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $10.63B | Feb 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.38B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $76.05B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $73.78B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $71.02B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $69.09B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $66.56B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $65.86B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $63.23B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $60.43B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $65.50B | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.27B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $10.83B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $9.37B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $9.52B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $9.68B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $6.80B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $6.48B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $9.08B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $6.10B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $8.56B | Feb 21, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $37.51B | Feb 20, 2024 |
| FY2023 | Dec 31, 2022 | $36.78B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $39.45B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $40.61B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $31.77B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $30.38B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $34.48B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $33.21B | Feb 23, 2018 |
| FY2016 | Dec 31, 2015 | $30.99B | Feb 24, 2017 |
| FY2015 | Dec 31, 2014 | $22.62B | Feb 25, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 21, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 21, 2019 |